Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sunday, April 20, 2025
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Pharma
Pharma
Pharma
FDA Approves Neurelis’ VALTOCO Nasal Spray for Seizure Clusters in Children as Young as 2
Life Sciences Times
-
April 16, 2025
Pharma
MindMed Doses First Patient in Phase 3 Trial of LSD-Based Therapy for Major Depressive Disorder
Life Sciences Times
-
April 15, 2025
Pharma
Scipher Medicine and Kythera Labs Join Forces to Advance Precision Treatment for Autoimmune Diseases
Life Sciences Times
-
April 15, 2025
Pharma
Pfizer Halts Development of Oral Weight Loss Drug Danuglipron
Life Sciences Times
-
April 14, 2025
Pharma
Pheast Therapeutics Begins Phase 1 Trial of Macrophage Checkpoint Inhibitor PHST001 for Advanced Solid Tumors
Life Sciences Times
-
April 14, 2025
Pharma
bit.bio’s New Huntington’s Disease Human Cell Model Set to Accelerate Drug Discovery and Screening
Life Sciences Times
-
May 9, 2022
0
Pharma
Twist Bioscience Enters into Research, Exclusive Option and License Agreement with Astellas for Antibodies to Reduce Tumor Microenvironment-Mediated Immunosuppression
Life Sciences Times
-
May 9, 2022
0
Pharma
Comera Life Sciences Announces Research Collaboration with Top 10 Pharmaceutical Company to Develop Subcutaneous Formulation
Life Sciences Times
-
May 9, 2022
0
Pharma
Alzamend Neuro Announces Initiation of Phase IIA Multiple Ascending Dose Clinical Trial for AL001 Treatment of Dementia Related to Alzheimer’s
Life Sciences Times
-
May 5, 2022
0
Pharma
Medicago Announces Publication of Phase 3 COVID-19 Vaccine Study Results in New England Journal of Medicine
Life Sciences Times
-
May 5, 2022
0
Pharma
Horizon Therapeutics plc Receives European Commission (EC) Approval of UPLIZNA® (inebilizumab) for the Treatment of Adults With Neuromyelitis Optica Spectrum Disorder (NMOSD)
Life Sciences Times
-
May 2, 2022
0
Pharma
ULTOMIRIS® (ravulizumab-cwvz) Approved in the US for Adults with Generalized Myasthenia Gravis
Life Sciences Times
-
April 28, 2022
0
Pharma
Valneva and Pfizer Report Positive Phase 2 Pediatric Data for Lyme Disease Vaccine Candidate
Life Sciences Times
-
April 26, 2022
0
Pharma
Virpax Successfully Completes Initial Preclinical Studies for VRP324
Life Sciences Times
-
April 26, 2022
0
Pharma
Several New Studies Presented at ECCMIC 2022 Confirm Veklury® (Remdesivir) Activity in Treating COVID-19
Life Sciences Times
-
April 25, 2022
0
Pharma
ImmunityBio Announces First Participants Have Been Enrolled in Lung-MAP Trial Studying Anktiva to Activate NK and T Cells in Non-Small Cell Lung Cancer
Life Sciences Times
-
April 25, 2022
0
Pharma
Takeda Presents New Exploratory Analysis Showing Patients Treated With LIVTENCITY™ (Maribavir) Had Reductions in Hospitalization Rates and Length of Hospital Stay
Life Sciences Times
-
April 22, 2022
0
1
...
25
26
27
...
62
Page 26 of 62
Most Read
Alis Biosciences Launches Fund to Unlock $30 Billion in Trapped Capital from Struggling Biotech Firms
April 18, 2025
$2.25 Million Settlement Reached in Effexor XR® Class-Action Lawsuit Involving Teva Pharmaceuticals
April 18, 2025
Tempus Forms Advisory Board of Leading Physicians to Guide AI-Driven Precision Medicine
April 18, 2025
Beneath the biotech boom
April 17, 2025